Stable oral availability of sustained release propranolol when co‐ administered with hydralazine or food: evidence implicating substrate delivery rate as a determinant of presystemic drug interactions.
Open Access
- 1 February 1984
- journal article
- Published by Wiley in British Journal of Clinical Pharmacology
- Vol. 17 (S1), 45S-50S
- https://doi.org/10.1111/j.1365-2125.1984.tb02427.x
Abstract
A study was made of the influence of hydralazine on the oral availability of a sustained release formulation of propranolol (Inderal LA). Sustained release propranolol 160 mg was given orally either alone or in combination with oral hydralazine 25 mg on separate occasions to six healthy volunteers. Blood and urine samples were collected post- dosing over 34 h. Peak concentrations of propranolol, time to peak and area under the plasma concentration-time curve (AUC) were not altered by co-administration of hydralazine with sustained release propranolol. Similarly, there was no change in recovery of 11C-labelled propranolol and metabolites in those individuals to whom tracer label was given. These results contrast with previous reports of marked interaction between the conventional formulation of propranolol and hydralazine or food. Interactions were confirmed between hydralazine and conventional propranolol in three subjects who had been studied previously with sustained release propranolol. Analysis of metabolite profiles in one of these subjects established that the major metabolites do change under hydralazine stimulus. These results indicate that substrate delivery rates may determine presystemic drug interactions, suggesting capacity limitations of hydroxylation processes or short-term flow redistribution following hydralazine, resulting in functional shunting past the hydroxylation enzymes. These results exclude global or lasting enzyme inhibition by hydralazine or simple flow-sensitivity of presystemic clearance.Keywords
This publication has 18 references indexed in Scilit:
- A Study of the Percutaneous Absorption from Topically Applied Zinc Oxide OintmentJournal of Parenteral and Enteral Nutrition, 1983
- Influence of Food Intake on Presystemic Clearance of DrugsClinical Pharmacokinetics, 1983
- Stable Oral Availability of Atenolol Coadministered with HydralazineDrugs, 1983
- The effect of hydralazine on the pharmacokinetics of three different beta adrenoceptor antagonists: Metoprolol, nadolol, and acebutololBiopharmaceutics & Drug Disposition, 1982
- Combined High-performance Liquid Chromatographic Procedure for Measuring 4-hydroxypropranolol and Propranolol in Plasma: Pharmacokinetic Measurements Following Conventional and Slow-Release Propranolol AdministrationJournal of Pharmaceutical Sciences, 1981
- Pharmacokinetics of propranololJournal of Pharmacokinetics and Biopharmaceutics, 1981
- Interaction between oral propranolol and hydralazineClinical Pharmacology & Therapeutics, 1980
- BETA-BLOCKADE AND BLOOD-LEVELS AFTER LOW-DOSE ORAL PROPRANOLOL: THE HEPATIC "FIRST-PASS" THRESHOLD REVISITEDThe Lancet, 1978
- Hepatic clearance of drugs. I. Theoretical considerations of a “well-stirred” model and a “parallel tube” model. Influence of hepatic blood flow, plasma and blood cell binding, and the hepatocellular enzymatic activity on hepatic drug clearanceJournal of Pharmacokinetics and Biopharmaceutics, 1977
- Pharmacokinetics of propranolol in normal healthy volunteersJournal of Pharmacokinetics and Biopharmaceutics, 1977